{"name":"Inveni Capital","permalink":"inveni-capital","crunchbase_url":"http://www.crunchbase.com/financial-organization/inveni-capital","homepage_url":"http://www.invenicapital.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"+ 358 400 874 546","description":"Venture Capital","email_address":"mfagerlund@invenicapital.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Sun Jun 21 05:32:26 UTC 2009","updated_at":"Sun Jun 21 05:36:46 UTC 2009","overview":"<p>Inveni Capital, with offices in Finland and Germany, is a new venture capital management company with some â‚¬ 30 million under management investing in early to growthâ€“stage life science (pharma and medtech) companies in Northern and Central Europe. Inveni Capital, with its experienced team, will be a highly engaged investor in its portfolio companies.</p>","image":{"available_sizes":[[[150,52],"assets/images/resized/0004/9925/49925v2-max-150x150.jpg"],[[219,77],"assets/images/resized/0004/9925/49925v2-max-250x250.jpg"],[[219,77],"assets/images/resized/0004/9925/49925v2-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"Helsinki Office","address1":"Biomedicum 2, Tukholmankatu 8A","address2":"","zip_code":"FIN-00290 ","city":"Helsinki","state_code":null,"country_code":"FIN","latitude":null,"longitude":null},{"description":"Munich Office ","address1":"Rumfordstr. 10","address2":"","zip_code":"D-80469","city":"Munich","state_code":null,"country_code":"DEU","latitude":48.1331906,"longitude":11.5762567}],"relationships":[{"is_past":false,"title":"Partner","person":{"first_name":"Markku","last_name":"Fagerlund","permalink":"markku-fagerlund","image":{"available_sizes":[[[102,150],"assets/images/resized/0004/9926/49926v1-max-150x150.jpg"],[[120,175],"assets/images/resized/0004/9926/49926v1-max-250x250.jpg"],[[120,175],"assets/images/resized/0004/9926/49926v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner","person":{"first_name":"Dr.","last_name":"Wolfgang Pieken","permalink":"dr-wolfgang-pieken","image":{"available_sizes":[[[102,150],"assets/images/resized/0004/9928/49928v1-max-150x150.jpg"],[[120,175],"assets/images/resized/0004/9928/49928v1-max-250x250.jpg"],[[120,175],"assets/images/resized/0004/9928/49928v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner","person":{"first_name":"Aki","last_name":"Prihti","permalink":"aki-prihti","image":{"available_sizes":[[[102,150],"assets/images/resized/0004/9927/49927v1-max-150x150.jpg"],[[120,175],"assets/images/resized/0004/9927/49927v1-max-250x250.jpg"],[[120,175],"assets/images/resized/0004/9927/49927v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.medicalnewstoday.com/articles/135539.php","source_description":"Ark Grants VEGF Genes Licence To Oy Lx Therapies Ltd For Lymphatic Disease","raised_amount":2630000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":14,"company":{"name":"OY LX Therapies","permalink":"oy-lx-therapies","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/09/laurantis-pharma-completes-e5-64m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Laurantis Pharma Completes €5.64M Funding","raised_amount":5640000,"raised_currency_code":"EUR","funded_year":2012,"funded_month":9,"funded_day":4,"company":{"name":"Laurantis Pharma","permalink":"laurantis-pharma","image":{"available_sizes":[[[150,59],"assets/images/resized/0020/9611/209611v1-max-150x150.jpg"],[[186,74],"assets/images/resized/0020/9611/209611v1-max-250x250.jpg"],[[186,74],"assets/images/resized/0020/9611/209611v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}